Kay L. Saywell

Pharmacokinetics of Valganciclovir and Ganciclovir Following Multiple Oral Dosages of Valganciclovir in HIV- and CMV-Seropositive Volunteers

Frances C. Brown, Ludger Banken, Kay L. Saywell et al. · Clinical Pharmacokinetics · 1999 · 156 citations

Medicine, Pharmacokinetics, Pharmacology +11

Effect of Plasma Protein Binding on in Vivo Activity and Brain Penetration of Glycine/NMDA Receptor Antagonists

Michael Rowley, Janusz J. Kulagowski, Alan P. Watt et al. · Journal of Medicinal Chemistry · 1997 · 129 citations

Medicine, Neuroscience, Pharmacology +17

L-745,870, a Subtype Selective Dopamine D4 Receptor Antagonist, Does Not Exhibit a Neuroleptic-Like Profile in Rodent Behavioral Tests

Linda J. Bristow, Neil Collinson, Gina P Cook et al. · Journal of Pharmacology and Experimental Therapeutics · 1997 · 105 citations

Medicine, Behavioral Sciences, Pharmacology +16

Anticonvulsant activity of glycine-site NMDA antagonists. 2. trans 2-carboxy-4-substituted tetrahydroquinolines.

Robert W. Carling, Paul D. Leeson, Angela M. Moseley et al. · Bioorganic & Medicinal Chemistry Letters · 1993 · 85 citations

Medicine, Neuroscience, Pharmacology +11

Rat Strain Differences in the Ability to Disrupt Sensorimotor Gating Are Limited to the Dopaminergic System, Specific to Prepulse Inhibition, and Unrelated to Changes in Startle Amplitude or Nucleus Accumbens Dopamine Receptor Sensitivity

Gene G. Kinney, Lynn O. Wilkinson, Kay L. Saywell et al. · Journal of Neuroscience · 1999 · 82 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17